| No headlines available for HIVBX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 470.00K | | Category: | Large Value | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 26.01% | | 5y Avg Return: | 0.66% | | Rank in Category (ytd): | 271 | | % Rank in Category (ytd): | 20.96% | | Beta (3y): | 1.08 | | Morningstar Risk Rating: | Above average |
|
| The investment seeks long-term growth of capital and income. The fund invests all of assets in the HSBC Investor Value portfolio which primarily invests in U.S. and foreign equity securities of companies with large and medium capitalizations that possess opportunities underappreciated or misperceived by the market. The portfolio may also invest up to 25% of assets in dollar-denominated securities of non-U.S. issuers up to 20% of assets in bonds and other debt securities. | | | Fund Profile |
|
Help
0.14 (1.38%) 
Summary
Add HIVBX to Portfolio 
Download Data
